Fund structure

Fund structure09.17.2021

Aescap Life Sciences
Aescap Genetics
Performance
Fund structure
Fund management
Fund setup

Attend our meetings

News

Portfolio News – Acquisition of Portfolio Company Dicerna – Nov 18, 2021 November 23, 2021
Aescap Life Sciences Quarterly Update Q3 2021 October 6, 2021
Facts & Figures – From History to Future in Cancer Treatment October 1, 2021

Aescap Life Sciences
Barbara Strozzilaan 101, 1083 HN Amsterdam, Nederland
Tel. + 31 20 570 29 40 E-mail: pkrol@aescap.com
Alle rechten voorbehouden. © 2021

Do not run any unnecessary risk. Read the Key Information Document and the Key Investor Information Document (the Key Investor Information Document is available for the Aescap Life Sciences Investors and the Aescap Life Sciences Investors Class <500k only). This communication is neither an offer to sell nor a solicitation to invest. Past performance is not indicative of future results. The value of investments and any income generated may go down as well as up and is not guaranteed. Privium Fund Management B.V. (Privium) is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM). The Fund and its manager, Privium Fund Management B.V., are held in the register of Dutch Authority for the Financial Markets. The Prospectus of the Fund, the Key Information Document and the Key Investor Information Document can be downloaded via the website of the Fund (www.aescap.com) and the Fund Manager (www.priviumfund.com). The performance overviews shown in this communication have been carefully composed by Privium Fund Management B.V. No rights can be derived from this communication.